Learning Objectives


1. Identify neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte globulin (MOG) associated disorder as a cause of a patient’s optic              nerve disease.
2. Explain the current evaluation and management of NMOSD and MOG.
3. Discuss the ways that recommendations for evaluation and management of these disorders may change in the future.. 



Click here to complete today’s evaluation: https://ce.icep.wisc.edu/neurology-grand-rounds-20-22-eval-15135

Session date: 
11/30/2020 - 4:00pm to 5:00pm CST
Medical Foundation Centennial Bldg, Room #1220
1685 Highland Ave
Madison, WI 53705
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Ivy Dreizin, M.D., Natasha Frost, M.D.